Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_assertion type Assertion NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_head.
- NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_assertion description "[Delineation of the adverse prognostic power of MDR1 in adult acute myeloid leukemia (AML) raised hopes that pharmacologic blockade of P-gp would improve the outcome of conventional cytotoxic therapy, perhaps more so than in any other human malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_provenance.
- NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_assertion evidence source_evidence_literature NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_provenance.
- NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_assertion SIO_000772 15217827 NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_provenance.
- NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_assertion wasDerivedFrom befree-2016 NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_provenance.
- NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_assertion wasGeneratedBy ECO_0000203 NP449660.RAcZglI5wj5YIIwAW3Ju4FcW5lDUZNV_5_2yUTJXhwfhE130_provenance.